PLYMOUTH, Minn., July 22, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) will release its 2009 second quarter financial results on Tuesday, July 28, 2009, before regular market trading hours.
The company will host a conference call and webcast the same day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). ev3 management will review its second quarter results and future outlook, followed by a question and answer session.
The conference call will be available to interested parties through a live audio webcast at http://ir.ev3.net, where it will be archived and accessible for approximately 12 months. The live dial-in number for the call is 888-679-8040 (U.S.) or 617-213-4851 (International). The participant passcode is 31069484.
If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888 (International) and enter passcode 80793229. The audio replay will be available beginning at 10:30 a.m. Central Time on Tuesday, July 28, 2009 until Tuesday, August 4, 2009.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils and flow diversion devices, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.